首页> 外文期刊>Journal of Artificial Organs >Combined blood purification for treating acute fatty liver of pregnancy complicated by acute kidney injury: a case series
【24h】

Combined blood purification for treating acute fatty liver of pregnancy complicated by acute kidney injury: a case series

机译:联合血液净化治疗妊娠合并急性脂肪肝合并急性肾损伤一例

获取原文
获取原文并翻译 | 示例
           

摘要

Acute fatty liver of pregnancy (AFLP) complicated by acute kidney injury (AKI) is serious and life-threatening for the mother. The present study aimed to determine the clinical efficacy of combined blood purification treatment (CBPT) in patients with AFLP complicated by AKI. The CBPT involves plasma exchange (PE) combined with continuous venovenous hemofiltration (CVVH). The subjects were 17 patients with AFLP complicated by AKI. The CBPT was implemented based on the timely termination of pregnancy and general treatment. Changes in clinical manifestations, laboratory tests, liver ultrasounds, as well as Sequential Organ Failure Assessment (SOFA) and Glasgow scores were evaluated. The efficacy and adverse reactions of the CBPT were also assessed. The CBPT was smoothly performed without any obvious adverse reaction. After treatment, the clinical manifestations, laboratory examinations, and liver ultrasonography significantly improved. Therefore, the SOFA scores correspondingly decreased 1 week after treatment [9 (range 5–11) vs. 3 (range 0–10), P = 0.002], and the median was close to normal by the second week. The clearance rate of the total bilirubin in PE was significantly higher than that in CVVH (37.2 vs. 7.9%, P = 0.000). The incidence of acute pulmonary edema in CVVH was less than that in PE (0 vs. 41.2%, P = 0.007). Finally, the maternal mortality was 5.88% (95% CI: 0–29%). Overall, we think that CBPT aids in the recovery of liver and kidney function. Different blood purification methods may be combined to integrate and maximize their advantages to improve the prognoses of patients with serious AFLP.
机译:孕妇的急性脂肪肝(AFLP)并发急性肾损伤(AKI)非常严重,并危及母亲的生命。本研究旨在确定联合血液净化治疗(CBPT)在AFLP合并AKI患者中的临床疗效。 CBPT涉及血浆置换(PE)和连续静脉血液滤过(CVVH)。受试者为17例AFLP合并AKI的患者。 CBPT是在及时终止妊娠和一般治疗的基础上实施的。评估了临床表现,实验室检查,肝超声以及顺序器官衰竭评估(SOFA)和格拉斯哥评分的变化。还评估了CBPT的疗效和不良反应。 CBPT顺利进行,没有任何明显的不良反应。治疗后,临床表现,实验室检查和肝脏超声检查均明显改善。因此,治疗后1周SOFA评分相应降低[9(范围5-11)对3(范围0-10),P = 0.002],并且第二周的中位值接近正常。 PE中总胆红素的清除率显着高于CVVH(37.2比7.9%,P = 0.000)。 CVVH的急性肺水肿的发生率低于PE(0比41.2%,P = 0.007)。最后,孕产妇死亡率为5.88%(95%CI:0–29%)。总体而言,我们认为CBPT有助于肝脏和肾脏功能的恢复。可以组合使用不同的血液净化方法,以整合和最大化其优势,以改善严重AFLP患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号